On December 18, 2025, AstraZeneca-CICC Healthcare Industry Fund announced the completion of its Pre-A round financing for Hangzhou HeSheng Technology Co., Ltd. This round of financing was led by them, with participation from institutions such as SMIC Capital, Hangzhou Hi-Tech Golden Investment, and Shanghai Zhuopu.
